Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases
Identifieur interne : 000413 ( Main/Exploration ); précédent : 000412; suivant : 000414Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases
Auteurs : Tajrena Alexi [Nouvelle-Zélande] ; Cesario V. Borlongan [États-Unis] ; Richard L. M. Faull [Nouvelle-Zélande] ; Chris E. Williams [Nouvelle-Zélande] ; Ross G. Clark [Nouvelle-Zélande] ; Peter D. Gluckman [Nouvelle-Zélande] ; Paul E. Hughes [Nouvelle-Zélande]Source :
- Progress in Neurobiology [ 0301-0082 ] ; 2000.
Abstract
There are three main mechanisms of neuronal cell death which may act separately or cooperatively to cause neurodegeneration. This lethal triplet of metabolic compromise, excitotoxicity, and oxidative stress causes neuronal cell death that is both necrotic and apoptotic in nature. Aspects of each of these three mechanisms are believed to play a role in the neurodegeneration that occurs in both Parkinson’s and Huntington’s diseases. Strategies to rescue or protect injured neurons usually involve promoting neuronal growth and function or interfering with neurotoxic processes. Considerable research has been done on testing a large array of neuroprotective agents using animal models which mimic these disorders. Some of these approaches have progressed to the clinical arena. Here, we review neuroprotective strategies which have been found to successfully ameliorate the neurodegeneration associated with Parkinson’s and Huntington’s diseases. First, we will give an overview of the mechanisms of cell death and the background of Parkinson’s and Huntington’s diseases. Then we will elaborate on a range of neuroprotective strategies, including neurotrophic factors, anti-excitotoxins, antioxidants, bioenergetic supplements, anti-apoptotics, immunosuppressants, and cell transplantation techniques. Most of these approaches hold promise as potential therapies in the treatment of these disorders.
Url:
DOI: 10.1016/S0301-0082(99)00032-5
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000380
- to stream Istex, to step Curation: 000224
- to stream Istex, to step Checkpoint: 000184
- to stream Main, to step Merge: 000414
- to stream Main, to step Curation: 000413
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases</title><author><name sortKey="Alexi, Tajrena" sort="Alexi, Tajrena" uniqKey="Alexi T" first="Tajrena" last="Alexi">Tajrena Alexi</name></author><author><name sortKey="Borlongan, Cesario V" sort="Borlongan, Cesario V" uniqKey="Borlongan C" first="Cesario V." last="Borlongan">Cesario V. Borlongan</name></author><author><name sortKey="Faull, Richard L M" sort="Faull, Richard L M" uniqKey="Faull R" first="Richard L. M." last="Faull">Richard L. M. Faull</name></author><author><name sortKey="Williams, Chris E" sort="Williams, Chris E" uniqKey="Williams C" first="Chris E." last="Williams">Chris E. Williams</name></author><author><name sortKey="Clark, Ross G" sort="Clark, Ross G" uniqKey="Clark R" first="Ross G." last="Clark">Ross G. Clark</name></author><author><name sortKey="Gluckman, Peter D" sort="Gluckman, Peter D" uniqKey="Gluckman P" first="Peter D." last="Gluckman">Peter D. Gluckman</name></author><author><name sortKey="Hughes, Paul E" sort="Hughes, Paul E" uniqKey="Hughes P" first="Paul E." last="Hughes">Paul E. Hughes</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A5141262231446D599DF5115C9C1597A402317CB</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0301-0082(99)00032-5</idno><idno type="url">https://api.istex.fr/document/A5141262231446D599DF5115C9C1597A402317CB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000380</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000380</idno><idno type="wicri:Area/Istex/Curation">000224</idno><idno type="wicri:Area/Istex/Checkpoint">000184</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000184</idno><idno type="wicri:doubleKey">0301-0082:2000:Alexi T:neuroprotective:strategies:for</idno><idno type="wicri:Area/Main/Merge">000414</idno><idno type="wicri:Area/Main/Curation">000413</idno><idno type="wicri:Area/Main/Exploration">000413</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases</title><author><name sortKey="Alexi, Tajrena" sort="Alexi, Tajrena" uniqKey="Alexi T" first="Tajrena" last="Alexi">Tajrena Alexi</name><affiliation wicri:level="1"><country wicri:rule="url">Nouvelle-Zélande</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Research Centre for Developmental Medicine and Biology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author><author><name sortKey="Borlongan, Cesario V" sort="Borlongan, Cesario V" uniqKey="Borlongan C" first="Cesario V." last="Borlongan">Cesario V. Borlongan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cellular Neurobiology, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Faull, Richard L M" sort="Faull, Richard L M" uniqKey="Faull R" first="Richard L. M." last="Faull">Richard L. M. Faull</name><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Anatomy with Radiology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author><author><name sortKey="Williams, Chris E" sort="Williams, Chris E" uniqKey="Williams C" first="Chris E." last="Williams">Chris E. Williams</name><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Research Centre for Developmental Medicine and Biology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author><author><name sortKey="Clark, Ross G" sort="Clark, Ross G" uniqKey="Clark R" first="Ross G." last="Clark">Ross G. Clark</name><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Research Centre for Developmental Medicine and Biology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author><author><name sortKey="Gluckman, Peter D" sort="Gluckman, Peter D" uniqKey="Gluckman P" first="Peter D." last="Gluckman">Peter D. Gluckman</name><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Research Centre for Developmental Medicine and Biology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author><author><name sortKey="Hughes, Paul E" sort="Hughes, Paul E" uniqKey="Hughes P" first="Paul E." last="Hughes">Paul E. Hughes</name><affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country><wicri:regionArea>Department of Pharmacology and Clinical Pharmacology, School of Medicine, University of Auckland, Auckland</wicri:regionArea><wicri:noRegion>Auckland</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Progress in Neurobiology</title><title level="j" type="abbrev">PRONEU</title><idno type="ISSN">0301-0082</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">60</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="409">409</biblScope><biblScope unit="page" to="470">470</biblScope></imprint><idno type="ISSN">0301-0082</idno></series><idno type="istex">A5141262231446D599DF5115C9C1597A402317CB</idno><idno type="DOI">10.1016/S0301-0082(99)00032-5</idno><idno type="PII">S0301-0082(99)00032-5</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0301-0082</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There are three main mechanisms of neuronal cell death which may act separately or cooperatively to cause neurodegeneration. This lethal triplet of metabolic compromise, excitotoxicity, and oxidative stress causes neuronal cell death that is both necrotic and apoptotic in nature. Aspects of each of these three mechanisms are believed to play a role in the neurodegeneration that occurs in both Parkinson’s and Huntington’s diseases. Strategies to rescue or protect injured neurons usually involve promoting neuronal growth and function or interfering with neurotoxic processes. Considerable research has been done on testing a large array of neuroprotective agents using animal models which mimic these disorders. Some of these approaches have progressed to the clinical arena. Here, we review neuroprotective strategies which have been found to successfully ameliorate the neurodegeneration associated with Parkinson’s and Huntington’s diseases. First, we will give an overview of the mechanisms of cell death and the background of Parkinson’s and Huntington’s diseases. Then we will elaborate on a range of neuroprotective strategies, including neurotrophic factors, anti-excitotoxins, antioxidants, bioenergetic supplements, anti-apoptotics, immunosuppressants, and cell transplantation techniques. Most of these approaches hold promise as potential therapies in the treatment of these disorders.</div></front></TEI><affiliations><list><country><li>Nouvelle-Zélande</li><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="Nouvelle-Zélande"><noRegion><name sortKey="Alexi, Tajrena" sort="Alexi, Tajrena" uniqKey="Alexi T" first="Tajrena" last="Alexi">Tajrena Alexi</name></noRegion><name sortKey="Alexi, Tajrena" sort="Alexi, Tajrena" uniqKey="Alexi T" first="Tajrena" last="Alexi">Tajrena Alexi</name><name sortKey="Clark, Ross G" sort="Clark, Ross G" uniqKey="Clark R" first="Ross G." last="Clark">Ross G. Clark</name><name sortKey="Faull, Richard L M" sort="Faull, Richard L M" uniqKey="Faull R" first="Richard L. M." last="Faull">Richard L. M. Faull</name><name sortKey="Gluckman, Peter D" sort="Gluckman, Peter D" uniqKey="Gluckman P" first="Peter D." last="Gluckman">Peter D. Gluckman</name><name sortKey="Hughes, Paul E" sort="Hughes, Paul E" uniqKey="Hughes P" first="Paul E." last="Hughes">Paul E. Hughes</name><name sortKey="Williams, Chris E" sort="Williams, Chris E" uniqKey="Williams C" first="Chris E." last="Williams">Chris E. Williams</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Borlongan, Cesario V" sort="Borlongan, Cesario V" uniqKey="Borlongan C" first="Cesario V." last="Borlongan">Cesario V. Borlongan</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000413 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000413 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= DanceTherParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A5141262231446D599DF5115C9C1597A402317CB
|texte= Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases
}}
| This area was generated with Dilib version V0.6.35. |  |